Get startedLog in
    Picture of Suven Life Sciences logo

    SUVEN — Suven Life Sciences Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Suven Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    C2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue13511813511766.6
    Cost of Revenue
    Gross Profit13411713210753.2
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses9751,3451,3951,3871,780
    Operating Profit-840-1,226-1,260-1,270-1,714
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-775-1,220-1,183-1,061-1,607
    Provision for Income Taxes
    Net Income After Taxes-722-1,220-1,183-1,051-1,607
    Net Income Before Extraordinary Items
    Net Income-722-1,220-1,183-1,051-1,607
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-722-1,220-1,183-1,051-1,607
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-5.22-9.32-6.97-5.04-7.37